ClinOne

ClinOne developed and commercialized a single digital platform to support patient recruitment, consent management (eConsent), virtual visits, transportation coordination (Uber Health), medication adherence tracking, and data insights in clinical trials. The company’s solutions are widely used by pharmaceutical sponsors and CROs to improve patient experience and site productivity in complex therapeutic areas such as oncology and rare diseases. In September 2024 it was acquired by uMotif. No clinical results as the company provides software/services rather than drugs. More than 80 sponsors/CROs/site networks have used its solutions across over 60 countries. Over half of supported trials were in oncology as of late 2023. Achieved consecutive years of >125% revenue growth prior to acquisition.